SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-005872
Filing Date
2023-02-23
Accepted
2023-02-23 16:05:38
Documents
16
Period of Report
2023-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54792
2 ex4-1.htm EX-4.1 101541
3 ex4-2.htm EX-4.2 95269
4 ex10-1.htm EX-10.1 222832
5 ex10-2.htm EX-10.2 30166
  Complete submission text file 0001493152-23-005872.txt   773067

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE invo-20230217.xsd EX-101.SCH 3245
7 XBRL LABEL FILE invo-20230217_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE invo-20230217_pre.xml EX-101.PRE 22371
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3433
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 23659586
SIC: 3841 Surgical & Medical Instruments & Apparatus